ANDA 77935, held by Tp Anda Holdings. Meloxicam.
As of Nov 14, 2026, ANDA 77935 (Meloxicam), held by Tp Anda Holdings, was first approved by FDA on Jul 19, 2006, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 19, 2006 | Original application | Approved |
| Nov 21, 2024 | Supplement 5Labeling · Standard review | Approved | None posted |
| Nov 18, 2024 | Supplement 4Labeling · Standard review | Approved | None posted |
| Jul 19, 2006 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
